Under construction – not a live service
Sign in
Taking people in BelgiumNo phase

Tests moderate aerobic exercise training in adults with persistent asthma

Tests whether moderate aerobic exercise helps adults with persistent asthma.

Plain-language title generated from the registry record
Registry title: SAMBA Trial: Towards a Paradigm Shift in Severe Asthma Management: Deep Analysis of the Effect of suBmaximal Aerobic Training

Key facts

Where
Liège, BelgiumSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Source: NCT04395937, who can take part

Where in Belgium

  • CHU LiègeLiège, BelgiumTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Liege
Trial code
NCT04395937
Record updated
14 April 2026
Original description
The effects of regular exercise on asthma control has not yet been well demonstrated.Read full original descriptionShow less

SAMBA Trial: Towards a Paradigm Shift in Severe Asthma Management: Deep Analysis of the Effect of suBmaximal Aerobic Training

The effects of regular exercise on asthma control has not yet been well demonstrated.

The aim of this study is to investigate the impact of submaximal aerobic training on exercise tolerance (VO2max - primary outcome) and a set of secondary outcomes: quality of life, asthma symptoms control, bronchial and systemic inflammatory markers, lung function, bronchial hyperresponsiveness, anxiety and depression and body composition in patients with persistant asthma.

Inclusion: asthmatic patient; aged 18- 65 years; ACQ > 1.5; stable background treatment comprising at least one inhaled corticosteroid or an anti-leukotriene.

Exclusion: Severe uncontrolled hypertension; IMC > 35; severe osteoarthritis of the knees and hips; unstable angor.

ClinicalTrials.gov NCT04395937